This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Glaxosmithkline Intellectual Property Management Limited, Glaxosmithkline Intellectual Property (No.2) Limited. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 9 
1 out of 95 
Years Active: 2021-2024
Title: **Robert B Henderson: Innovator in Autoimmune Treatment Solutions**
Introduction
Robert B Henderson, a prominent inventor based in Stevenage, GB, has made significant contributions to the field of autoimmune disorder treatment. With a solid background in research and development, he holds two patents that reflect his innovative work with antibodies, particularly in their application to combat diseases.
Latest Patents
Henderson's latest patents focus on dosing regimens and methods for treating autoimmune disorders utilizing a combination of CD20 binding antibodies and BLyS binding antibodies. The first patent details a combination of these antibodies aimed at depleting B cells and antagonizing BLyS. This invention includes specific information about dosages, duration of treatment, and recommended time lapses between the administration of the two antibodies, enhancing the effectiveness of the treatment. Additionally, the second patent mirrors the first, emphasizing the methodical approach to utilizing this combination in therapeutic settings.
Career Highlights
Robert B Henderson has built an impressive career within the pharmaceutical sector. He has worked with GlaxoSmithKline Intellectual Property Management Limited and GlaxoSmithKline Intellectual Property (No.2) Limited, engaging in intellectual property innovations that have propelled the company's research and development initiatives.
Collaborations
Throughout his career, Henderson has collaborated with various teams within the pharmaceutical industry, focusing on improving treatment methodologies for autoimmune disorders. His work, particularly in the realm of antibody therapies, underscores the importance of collaboration in bringing new medicinal solutions to market.
Conclusion
In summary, Robert B Henderson's impressive portfolio of patents and his innovative approaches to autoimmune treatment mark him as a key figure in the field. His work continues to influence the landscape of therapeutic solutions, showcasing the impact of dedicated inventors and their contributions to medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile